10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 230 filers reported holding 10X GENOMICS INC in Q3 2022. The put-call ratio across all filers is 0.78 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,245,750 | -85.1% | 30,200 | -79.9% | 0.00% | -85.7% |
| Q2 2023 | $8,369,690 | +497.7% | 149,887 | +497.2% | 0.02% | +425.0% |
| Q1 2023 | $1,400,329 | -83.7% | 25,100 | -89.3% | 0.00% | -85.2% |
| Q4 2022 | $8,586,831 | -15.1% | 235,643 | -33.7% | 0.03% | -20.6% |
| Q3 2022 | $10,115,000 | +46.7% | 355,168 | +133.0% | 0.03% | +47.8% |
| Q2 2022 | $6,896,000 | +41.6% | 152,406 | +138.0% | 0.02% | +64.3% |
| Q1 2022 | $4,871,000 | +184.4% | 64,038 | +456.9% | 0.01% | +366.7% |
| Q4 2021 | $1,713,000 | -89.0% | 11,500 | -86.6% | 0.00% | -92.5% |
| Q1 2021 | $15,552,000 | +56.2% | 85,921 | +22.2% | 0.04% | +37.9% |
| Q4 2020 | $9,954,000 | – | 70,300 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Venrock Management VI, LLC | 962,309 | $188,439,000 | 95.08% |
| Foresite Capital Management II, LLC | 1,753,528 | $343,376,000 | 92.37% |
| Foresite Capital Management I, LLC | 750,000 | $146,865,000 | 88.53% |
| 12 West Capital Management LP | 1,922,000 | $376,366,000 | 15.78% |
| Financial Consulate Inc. | 141,258 | $27,661,000 | 9.97% |
| FINANCIAL CONSULATE, INC | 141,258 | $27,661,000 | 9.97% |
| Meritech Capital Associates V L.L.C. | 1,793,871 | $351,276,000 | 7.51% |
| Andar Capital Management HK Ltd | 51,000 | $9,987,000 | 6.81% |
| JS Capital Management LLC | 540,589 | $105,858,000 | 5.12% |
| Renaissance Capital LLC | 97,281 | $19,050,000 | 3.01% |